Total Payments
$2,813
2024 Payments
$595.50
Companies
22
Transactions
160
Medicare Patients
888
Medicare Billing
$47,401
Payment Breakdown by Category
Food & Beverage$2,713 (96.4%)
Education$99.99 (3.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,713 | 159 | 96.4% |
| Education | $99.99 | 1 | 3.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $660.39 | 43 | $0 (2024) |
| Janssen Biotech, Inc. | $646.19 | 32 | $0 (2024) |
| Lilly USA, LLC | $287.59 | 16 | $0 (2024) |
| GENZYME CORPORATION | $183.78 | 10 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $154.73 | 9 | $0 (2024) |
| Incyte Corporation | $132.02 | 8 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $113.81 | 8 | $0 (2024) |
| Amgen Inc. | $112.29 | 6 | $0 (2024) |
| Ortho Dermatologics, a division of Bausch Health US, LLC | $111.95 | 6 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $62.65 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $595.50 | 39 | Janssen Biotech, Inc. ($142.25) |
| 2023 | $1,040 | 45 | Janssen Biotech, Inc. ($382.68) |
| 2022 | $468.80 | 26 | ABBVIE INC. ($83.06) |
| 2021 | $708.65 | 50 | AbbVie Inc. ($283.16) |
All Payment Transactions
160 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $19.31 | General |
| Category: Immunology | ||||||
| 12/13/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $17.37 | General |
| 12/12/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $4.71 | General |
| Category: Immunology | ||||||
| 12/12/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $4.48 | General |
| Category: Immunology | ||||||
| 11/04/2024 | Lilly USA, LLC | EBGLYSS (Drug) | Food and Beverage | In-kind items and services | $23.75 | General |
| Category: Immunology | ||||||
| 10/24/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $13.14 | General |
| Category: Dermatology | ||||||
| 10/24/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $4.79 | General |
| Category: Immunology | ||||||
| 10/22/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $16.41 | General |
| 10/17/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $18.23 | General |
| Category: IMMUNOLOGY | ||||||
| 09/24/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.68 | General |
| Category: Immunology | ||||||
| 09/19/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $20.34 | General |
| Category: Inflammation | ||||||
| 09/10/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $29.52 | General |
| Category: Dermatology | ||||||
| 08/29/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $22.04 | General |
| Category: Immunology | ||||||
| 08/29/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $1.50 | General |
| Category: Immunology | ||||||
| 08/28/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $16.43 | General |
| Category: Dermatology | ||||||
| 08/15/2024 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $18.63 | General |
| Category: Immunology | ||||||
| 08/13/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $25.28 | General |
| Category: IMMUNOLOGY | ||||||
| 08/13/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $2.29 | General |
| Category: Immunology | ||||||
| 07/31/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $18.12 | General |
| Category: Dermatology | ||||||
| 07/31/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $17.78 | General |
| Category: Immunology | ||||||
| 07/23/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | BLU-U (Medical Supply), Odomzo | Food and Beverage | In-kind items and services | $18.87 | General |
| Category: Dermatology | ||||||
| 07/03/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $14.66 | General |
| Category: Dermatology | ||||||
| 06/21/2024 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $20.14 | General |
| Category: Immunology | ||||||
| 06/11/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $3.13 | General |
| Category: Immunology | ||||||
| 06/10/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $20.58 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 279 | 473 | $42,396 | $13,817 |
| 2022 | 10 | 326 | 523 | $45,219 | $18,802 |
| 2021 | 6 | 138 | 249 | $28,925 | $7,698 |
| 2020 | 7 | 145 | 261 | $24,320 | $7,084 |
Total Patients
888
Total Services
1,506
Medicare Billing
$47,401
Procedure Codes
33
All Medicare Procedures & Services
33 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 58 | 93 | $10,996 | $4,367 | 39.7% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 43 | 47 | $6,914 | $1,963 | 28.4% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 27 | 33 | $5,167 | $1,940 | 37.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 25 | 25 | $3,675 | $1,200 | 32.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 12 | 15 | $2,339 | $1,070 | 45.8% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 34 | 43 | $4,088 | $1,013 | 24.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 28 | 33 | $2,230 | $938.65 | 42.1% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 28 | 154 | $4,416 | $542.09 | 12.3% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 11 | 17 | $1,295 | $452.59 | 35.0% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 13 | 13 | $1,277 | $328.64 | 25.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 52 | 68 | $6,286 | $3,744 | 59.6% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 56 | 67 | $9,220 | $3,715 | 40.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 53 | 53 | $6,996 | $3,306 | 47.3% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2022 | 26 | 50 | $3,650 | $1,532 | 42.0% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 32 | 45 | $4,000 | $1,417 | 35.4% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 16 | 19 | $2,486 | $1,386 | 55.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 27 | 33 | $1,905 | $1,211 | 63.6% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2022 | 26 | 26 | $2,427 | $952.63 | 39.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 13 | 13 | $1,941 | $900.69 | 46.4% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 25 | 149 | $6,308 | $637.63 | 10.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 38 | 43 | $10,611 | $3,078 | 29.0% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2021 | 28 | 31 | $6,109 | $1,650 | 27.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 15 | 20 | $3,510 | $1,131 | 32.2% |
| 17000 | Destruction of skin growth | Office | 2021 | 20 | 30 | $4,080 | $858.33 | 21.0% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 18 | 19 | $2,071 | $673.52 | 32.5% |
About Randi Toth
Randi Toth is a Family healthcare provider based in Akron, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/18/2015. The National Provider Identifier (NPI) number assigned to this provider is 1710356902.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Randi Toth has received a total of $2,813 in payments from pharmaceutical and medical device companies, with $595.50 received in 2024. These payments were reported across 160 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($2,713).
As a Medicare-enrolled provider, Toth has provided services to 888 Medicare beneficiaries, totaling 1,506 services with total Medicare billing of $47,401. Data is available for 4 years (2020–2023), covering 33 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Akron, OH
- Active Since 09/18/2015
- Last Updated 07/31/2017
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1710356902
Products in Payments
- TREMFYA (Drug) $524.93
- SKYRIZI (Biological) $326.53
- TALTZ (Drug) $263.84
- DUPIXENT (Biological) $246.43
- RINVOQ (Biological) $156.59
- HUMIRA (Biological) $145.44
- OPZELURA (Drug) $132.02
- Otezla (Drug) $95.78
- STELARA (Biological) $90.49
- JUBLIA (Drug) $73.89
- COSENTYX (Biological) $67.97
- Absorica LD (Drug) $56.75
- EUCRISA (Drug) $49.15
- COSENTYX (Drug) $45.84
- BOTOX (Biological) $42.14
- Seysara (Drug) $31.40
- ADBRY (Biological) $31.17
- REMICADE (Biological) $30.77
- Winlevi (Drug) $30.73
- ILUMYA (Biological) $29.52
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Akron
Sherita Cody, Aprn, Fnp-C, APRN, FNP-C
Family — Payments: $6,166
Family $6,166
Shannon Puliafico, Cnp, CNP
Family — Payments: $5,282
Family $5,282
Catherine Mensah, Cnp, CNP
Family — Payments: $4,860
Family $4,860
Erin Schellenberger, Fnp-C, FNP-C
Family — Payments: $4,437
Family $4,437
Mrs. Debra Mckinney, Nsn Aprn Fnp-C, NSN APRN FNP-C
Family — Payments: $4,051
Family $4,051
Lisa Nesline, Aprn Fnp, APRN FNP
Family — Payments: $3,588
Family $3,588